Cite
APA Citation
Samadder, N. J., Foster, N., McMurray, R., Burke, C. A., Stoffel, E., Kanth, P., Das, R., Cruz-Correa, M., Sanchez, E. V., Westover, M., Richmond, E., Della'Zanna, G., Rodriguez, L. M., Szabo, E., Zahrieh, D., & Limburg, P. (n.d.). s1331 Phase II Trial of Weekly Erlotinib Dosing to Reduce Duodenal Polyp Burden Associated With Familial Adenomatous Polyposis. American journal of gastroenterology, 116, S614. http://access.bl.uk/ark:/81055/vdc_100144524802.0x000026